Inspiring & original thinking. And, the latest news about us.
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
- KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time 06.28.21
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021 06.15.21
- Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update 06.10.21
- Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment 06.07.21
- Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care 06.03.21
- Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health 05.19.21
- U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing 04.22.21
- KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS) 04.20.21
- RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform 04.14.21
- Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions 04.08.21